{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:26:42Z","timestamp":1792664802914,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.clinbiochem.2019.04.010","type":"journal-article","created":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T17:02:31Z","timestamp":1555866151000},"page":"81-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["New molecular approaches to Alzheimer's disease"],"prefix":"10.1016","volume":"72","author":[{"given":"Chiara","family":"Di Resta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/gim.2015.117","article-title":"The genetic landscape of Alzheimer disease: clinical implications and perspectives","volume":"18","author":"Van Cauwenberghe","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0010","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fmed.2018.00108","article-title":"The role of genetics in advancing precision medicine for Alzheimer's disease-a narrative review","volume":"5","author":"Freudenberg-Hua","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer's disease facts and figures","volume":"12","author":"Alzheimer's Association","year":"2016","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: A systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinbiochem.2018.06.011","article-title":"Alzheimer's disease in the omics era","volume":"59","author":"Sancesario","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008897","article-title":"Prognosis of patients with dementia: results from a prospective nationwide registry linkage study in the Netherlands","volume":"5","author":"van de Vorst","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: A systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1750-3639.1991.tb00661.x","article-title":"Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections","volume":"1","author":"Braak","year":"1991","journal-title":"Brain Pathol. (Zurich, Switzerland)"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0050","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9343(97)00262-3","article-title":"Current concepts in the pathogenesis of Alzheimer's disease","volume":"103","author":"Carr","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0055","first-page":"38","article-title":"Rate of early onset Alzheimer's disease: a systematic review and meta-analysis","volume":"3","author":"Zhu","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0060","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0065","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1474-4422(10)70306-9","article-title":"Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE \u025b4 allele","volume":"10","author":"van der Flier","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1533317514545825","article-title":"The patterns of inheritance in early-onset dementia","volume":"30","author":"Jarmolowicz","year":"2015","journal-title":"Am. J. Alzheimer's Dis. Other Dementiasr."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0080","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2147\/CIA.S116724","article-title":"A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease","volume":"11","author":"An","year":"2016","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0085","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.2880399","article-title":"The genetic defect causing familial Alzheimer's disease maps on chromosome 21","volume":"235","author":"St George-Hyslop","year":"1987","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0090","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng1292-335","article-title":"Mapping of a gene predisposing to early\u2013onset Alzheimer's disease to chromosome 14q24.3","volume":"2","author":"Van Broeckhoven","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1533317514545825","article-title":"The patterns of inheritance in early-onset dementia","volume":"30","author":"Jarmolowicz","year":"2015","journal-title":"Am. J. Alzheimer's Dis. Other Dementiasr"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0105","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng1292-330","article-title":"Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14","volume":"2","author":"St George-Hyslop","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0110","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0115","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","article-title":"Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene","volume":"376","author":"Rogaev","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0120","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2147\/CIA.S85808","article-title":"Mutations in presenilin 2 and its implications in Alzheimer&rsquo;s disease and other dementia-associated disorders","volume":"10","author":"An","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/joim.12191","article-title":"Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014","volume":"275","author":"Schneider","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneurol.2011.221","article-title":"Autosomal recessive causes likely in early-onset Alzheimer disease","volume":"69","author":"Wingo","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0135","first-page":"316","article-title":"Physical mapping around the Alzheimer disease locus on the proximal long arm of chromosome 21","volume":"46","author":"Owen","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/alzrt107","article-title":"Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease","volume":"4","author":"Weggen","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0145","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/humu.22117","article-title":"Locus-specific mutation databases for neurodegenerative brain diseases","volume":"33","author":"Cruts","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0150","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1126\/science.1168979","article-title":"A recessive mutation in the APP gene with dominant-negative effect on Amyloidogenesis","volume":"323","author":"Di Fede","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0155","doi-asserted-by":"crossref","first-page":"30990","DOI":"10.1074\/jbc.M114.589069","article-title":"Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein","volume":"289","author":"Maloney","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer's disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0165","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early-onset Alzheimer's disease revisited","volume":"12","author":"Cacace","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0170","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng1292-330","article-title":"Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14","volume":"2","author":"St George-Hyslop","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.0.CO;2-J","article-title":"Presenilin mutations in Alzheimer's disease","volume":"11","author":"Cruts","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0180","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0185","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3233\/JAD-140081","article-title":"A novel PSEN1 mutation in a patient with sporadic early-onset Alzheimer's disease and prominent cerebellar ataxia","volume":"41","author":"Testi","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002270","article-title":"APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases","volume":"14","author":"Lanoisel\u00e9e","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0195","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1474-4422(16)00127-7","article-title":"Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond","volume":"15","author":"Cuyvers","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/alzrt26","article-title":"Genetics of Alzheimer disease in the pre- and post-GWAS era","volume":"2","author":"Ertekin-Taner","year":"2010","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0205","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0210","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0215","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0220","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0225","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ng0594-74","article-title":"Apolipoprotein E4 allele in a population\u2013based study of early\u2013onset Alzheimer's disease","volume":"7","author":"van Duijn","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0230","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopsych.2017.03.003","article-title":"Receptors, and modulation of Alzheimer's disease","volume":"83","author":"Zhao","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0235","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0240","first-page":"439","article-title":"Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex","volume":"60","author":"Bickeb\u00f6ller","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0245","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0250","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000211","article-title":"Alzheimer risk loci and associated neuropathology in a population-based study (Vantaa 85+)","volume":"4","author":"M\u00e4kel\u00e4","year":"2018","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0255","doi-asserted-by":"crossref","first-page":"D896","DOI":"10.1093\/nar\/gkw1133","article-title":"The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)","volume":"45","author":"MacArthur","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0260","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00439-010-0924-2","article-title":"Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease","volume":"129","author":"Belbin","year":"2011","journal-title":"Hum. Genet."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0265","first-page":"4","article-title":"Next-generation sequencing approach for the diagnosis of human diseases: open challenges and new opportunities","volume":"29","author":"Di Resta","year":"2018","journal-title":"EJIFCC"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0270","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neurobiolaging.2013.07.017","article-title":"Validation of next-generation sequencing technologies in genetic diagnosis of dementia","volume":"35","author":"Beck","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0275","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/mp.2012.15","article-title":"High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease","volume":"17","author":"Pottier","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0280","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1073\/pnas.0503689102","article-title":"Neuronal sorting protein-related receptor sorLA\/LR11 regulates processing of the amyloid precursor protein","volume":"102","author":"Andersen","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0285","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/archneur.61.8.1200","article-title":"Loss of Apolipoprotein E receptor LR11 in Alzheimer disease","volume":"61","author":"Scherzer","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0290","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.24305","article-title":"Coding mutations in SORL 1 and Alzheimer disease","volume":"77","author":"Vardarajan","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0295","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature12825","article-title":"Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease","volume":"505","author":"Cruchaga","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0300","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer's disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0305","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1093\/hmg\/ddp323","article-title":"Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity","volume":"18","author":"Kim","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0310","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.trsl.2014.05.006","article-title":"Epigenomics of Alzheimer's disease","volume":"165","author":"Bennett","year":"2015","journal-title":"Transl. Res."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0315","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/nn.3786","article-title":"Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci","volume":"17","author":"De Jager","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0320","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fnbeh.2015.00347","article-title":"Epigenetic alterations in Alzheimer's disease","volume":"9","author":"Sanchez-Mut","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0325","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1515\/revneuro-2017-0042","article-title":"MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms","volume":"29","author":"Dehghani","year":"2018","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0330","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00702-012-0781-3","article-title":"Multidimensional plasma protein separation technique for identification of potential Alzheimer's disease plasma biomarkers: a pilot study","volume":"119","author":"Henkel","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0335","doi-asserted-by":"crossref","first-page":"S289","DOI":"10.3233\/JAD-179904","article-title":"A blood test for Alzheimer's disease: progress, challenges and recommendations","volume":"64","author":"Kiddle","year":"2018","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0340","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fneur.2015.00236","article-title":"Blood-based proteomic biomarkers of Alzheimer's disease pathology","volume":"6","author":"Baird","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0345","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bbapap.2015.01.009","article-title":"Explorative and targeted neuroproteomics in Alzheimer's disease","volume":"1854","author":"Brinkmalm","year":"2015","journal-title":"Biochim. et Biophys. Acta (BBA)"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0350","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1515\/cclm-2018-0181","article-title":"Personalized laboratory medicine: a patient-centered future approach","volume":"56","author":"Prodan \u017ditnik","year":"2018","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0355","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2015-0171","article-title":"Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals\/academic schools of medicine in Europe","volume":"53","author":"Malentacchi","year":"2015","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0360","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3233\/JAD-142319","article-title":"Sphingomyelin SM(d18:1\/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-\u03b242, tau, and phospho-tau-181 levels","volume":"44","author":"Koal","year":"2015","journal-title":"JAD"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0365","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neurobiolaging.2016.11.007","article-title":"What success can teach us about failure: the plasma metabolome of older adults with superior memory and lessons for Alzheimer's disease","volume":"51","author":"Mapstone","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0370","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/GIM.0b013e31821d69b8","article-title":"Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of genetic Counselors","volume":"13","author":"Goldman","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0375","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","article-title":"Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis","volume":"83","author":"Ryman","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0380","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2015.01.001","article-title":"Exome sequencing and pathway analysis for identification of genetic variability relevant for bronchopulmonary dysplasia (BPD) in preterm newborns: a pilot study","volume":"451","author":"Carrera","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0390","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrg3463","article-title":"Disease-targeted sequencing: a cornerstone in the clinic","volume":"14","author":"Rehm","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0395","first-page":"215","article-title":"Next generation sequencing: from research area to clinical practice","volume":"29","author":"Di Resta","year":"2018","journal-title":"EJIFCC"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0400","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ng.2510","article-title":"Translating genes into health","volume":"45","author":"Kricka","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0405","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbapap.2015.01.016","article-title":"Neuroproteomics tools in clinical practice","volume":"1854","author":"Shevchenko","year":"2015","journal-title":"Biochim. et Biophys. Acta (BBA)"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0410","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and Memantine for moderate-to-severe Alzheimer's disease","volume":"366","author":"Howard","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0415","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.trci.2017.04.005","article-title":"Phase II clinical trials of anti-amyloid \u03b2 antibodies: When is enough, enough?","volume":"3","author":"Gold","year":"2017","journal-title":"Alzheimer's Dementia (New York, N Y)"},{"key":"10.1016\/j.clinbiochem.2019.04.010_bb0420","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jalz.2016.07.005","article-title":"The DIAN-TU next generation Alzheimer's prevention trial: adaptive design and disease progression model","volume":"13","author":"Bateman","year":"2017","journal-title":"Alzheimers Dement."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019303844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019303844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:54:20Z","timestamp":1757865260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912019303844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":83,"alternative-id":["S0009912019303844"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.04.010","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New molecular approaches to Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}